StockData
Precision Optics Corporation, Inc. logo

Precision Optics Corporation, Inc. (POCI) stock analysis

POCINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026Score 9/3020% below fair value
$5.00−0.05 (-0.99%)

Close on Nov 12, 2026Market cap $54.86MP/E –Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value2Growth2Performance3Health2Dividend0

Mixed9 of 30 checks passed

Precision Optics passes 9 of the 30 checks behind our score; 12 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
2/6
Growth
2/6
Past performance
3/6
Financial health
2/6
Dividend
0/6

What stands out

  • Trading below fair value

    The share price of $5.05 is below our fair value estimate of $6.29.

  • Low debt

    Debt is 6.3% of shareholders' equity, under the 40% we consider low.

  • Revenue growing 10%+ a year

    Revenue grew 14.4% a year over the last three fiscal years.

  • P/B below the industry

    Precision Optics's price-to-book of 2.72 is below the Surgical, Medical, and Dental Instruments and Supplies median of 3.22.

What to watch

  • Margin of safety under 20%

    The price is 19.7% below fair value, less than the 20% cushion we look for.

  • Return on equity under 15%

    Return on equity was -22.3% over the last twelve months and averaged -23.4% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -23.0%, below the 10% that usually covers the cost of capital.

  • Interest not well covered

    Operating income covers interest expense -23.7 times; we look for at least 5.

Valuation2/6
  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B below the industry

    Precision Optics's price-to-book of 2.72 is below the Surgical, Medical, and Dental Instruments and Supplies median of 3.22.

  • Trading below fair value

    The share price of $5.05 is below our fair value estimate of $6.29.

  • Margin of safety under 20%

    The price is 19.7% below fair value, less than the 20% cushion we look for.

Growth2/6
  • Revenue growing 10%+ a year

    Revenue grew 14.4% a year over the last three fiscal years.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 65.2% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

  • Guidance issued

    The latest outlook (fiscal year 2027 revenue, Sep 28, 2026) was issued for the first time, so it neither adds nor takes away points.

  • Gross margin slipping

    Gross margin was 17.2% over the last twelve months, against 17.8% a year earlier.

Past performance3/6
  • Return on equity under 15%

    Return on equity was -22.3% over the last twelve months and averaged -23.4% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -23.0%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Precision Optics's return on equity of -22.3% is above the Surgical, Medical, and Dental Instruments and Supplies median of -31.3%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was -11.5% over the last twelve months, against a 5-year average of -12.8%.

  • Net margin above the industry

    Precision Optics's net margin of -11.5% is above the Surgical, Medical, and Dental Instruments and Supplies median of -14.1%.

Financial health2/6
  • Low debt

    Debt is 6.3% of shareholders' equity, under the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 0.0% five years ago to 6.3%.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals -120% of total debt; we look for at least 20%.

  • Interest not well covered

    Operating income covers interest expense -23.7 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 2.28 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is 1.19; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    Precision Optics has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$6.29

The share price is 20% below this estimate.

20%+ below
Near fair value
20%+ above
$5.05Price$6.29Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/B3.2×3.2×3.2×$5.9650%
P/S2.3×1.8×2.8×$6.6350%
Fair value$6.29100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/B at month end
  • Own 5-year median 3.2
  • Surgical, Medical, and Dental Instruments and Supplies median 3.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$102.18K
Value traded per 1% price move
$56.23K

Downside

Medium risk

Typical loss in a bad month
22.0%
Volatility (annualized)
51%
Sharpe ratio, 1 year
0.30
Beta to the S&P 500 (5Y)
0.33

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2012 to 2026

Gross margin

17.2%−14.9 pts over 5 years

Operating margin

-11.1%−2.6 pts over 5 years

Net margin

-11.5%−10.5 pts over 5 years

See a number that looks wrong?